These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
316 related items for PubMed ID: 11417747
1. Indoloquinoxaline compounds that selectively antagonize P-glycoprotein. Smith CD, Myers CB, Zilfou JT, Smith SN, Lawrence DS. Oncol Res; 2000; 12(5):219-29. PubMed ID: 11417747 [Abstract] [Full Text] [Related]
2. Structure-activity studies of substituted quinoxalinones as multiple-drug-resistance antagonists. Lawrence DS, Copper JE, Smith CD. J Med Chem; 2001 Feb 15; 44(4):594-601. PubMed ID: 11170649 [Abstract] [Full Text] [Related]
3. Synthesis and evaluation of dihydropyrroloquinolines that selectively antagonize P-glycoprotein. Lee BD, Li Z, French KJ, Zhuang Y, Xia Z, Smith CD. J Med Chem; 2004 Mar 11; 47(6):1413-22. PubMed ID: 14998330 [Abstract] [Full Text] [Related]
4. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin. Limtrakul P, Chearwae W, Shukla S, Phisalphong C, Ambudkar SV. Mol Cell Biochem; 2007 Feb 11; 296(1-2):85-95. PubMed ID: 16960658 [Abstract] [Full Text] [Related]
5. Modulation of the spacer in N,N-bis(alkanol)amine aryl ester heterodimers led to the discovery of a series of highly potent P-glycoprotein-based multidrug resistance (MDR) modulators. Dei S, Braconi L, Trezza A, Menicatti M, Contino M, Coronnello M, Chiaramonte N, Manetti D, Perrone MG, Romanelli MN, Udomtanakunchai C, Colabufo NA, Bartolucci G, Spiga O, Salerno M, Teodori E. Eur J Med Chem; 2019 Jun 15; 172():71-94. PubMed ID: 30947123 [Abstract] [Full Text] [Related]
6. Reversal of P-glycoprotein mediated multidrug resistance by a newly synthesized 1,4-benzothiazipine derivative, JTV-519. Che XF, Nakajima Y, Sumizawa T, Ikeda R, Ren XQ, Zheng CL, Mukai M, Furukawa T, Haraguchi M, Gao H, Sugimoto Y, Akiyama S. Cancer Lett; 2002 Dec 10; 187(1-2):111-9. PubMed ID: 12359358 [Abstract] [Full Text] [Related]
7. Inhibition of P-glycoprotein (ABCB1)- and multidrug resistance-associated protein 1 (ABCC1)-mediated transport by the orally administered inhibitor, CBT-1((R)). Robey RW, Shukla S, Finley EM, Oldham RK, Barnett D, Ambudkar SV, Fojo T, Bates SE. Biochem Pharmacol; 2008 Mar 15; 75(6):1302-12. PubMed ID: 18234154 [Abstract] [Full Text] [Related]
8. Reversal of vinblastine resistance in human leukemic cells by haloperidol and dihydrohaloperidol. Kataoka Y, Ishikawa M, Miura M, Takeshita M, Fujita R, Furusawa S, Takayanagi M, Takayanagi Y, Sasaki K. Biol Pharm Bull; 2001 Jun 15; 24(6):612-7. PubMed ID: 11411546 [Abstract] [Full Text] [Related]
10. Localization of the 1,4-dihydropyridine drug acceptor of P-glycoprotein to a cytoplasmic domain using a permanently charged derivative N-methyl dexniguldipine. Ferry D, Boer R, Callaghan R, Ulrich WR. Int J Clin Pharmacol Ther; 2000 Mar 15; 38(3):130-40. PubMed ID: 10739116 [Abstract] [Full Text] [Related]
14. Modulation of P-glycoprotein expression and function by curcumin in multidrug-resistant human KB cells. Anuchapreeda S, Leechanachai P, Smith MM, Ambudkar SV, Limtrakul PN. Biochem Pharmacol; 2002 Aug 15; 64(4):573-82. PubMed ID: 12167476 [Abstract] [Full Text] [Related]